Coeliac disease in patients with short stature: A tertiary care centre experience

Prashant Singh1, Piyush Kumar Sharma1, Abhishek Agnihotri1

  • 1Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.

Insights

Approximately 11% of children with short stature have coeliac disease. Chronic diarrhoea and anaemia are key predictors, with significant growth improvement on a gluten-free diet.

Area of Science:

  • Paediatric Endocrinology
  • Gastroenterology
  • Genetics

Background:

  • Short stature affects a significant number of children, with diverse underlying causes.
  • Coeliac disease, an autoimmune disorder triggered by gluten, can manifest with growth impairment.

Purpose of the Study:

  • To determine the prevalence of coeliac disease in children with short stature.
  • To identify predictors of coeliac disease in this pediatric population.

Main Methods:

  • Retrospective review of 432 children with short stature evaluated between 2008-2011.
  • Screening for coeliac disease using IgA-anti-tissue transglutaminase antibody.
  • Diagnosis confirmed using modified European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) criteria.

Main Results:

  • Coeliac disease was diagnosed in 10.9% of children with short stature.
  • Chronic diarrhoea (OR 15.7) and anaemia (OR 4.9) were significant predictors.
  • Patients showed improved growth velocity (8.1 cm/year) on a gluten-free diet.

Conclusions:

  • Coeliac disease is a notable cause of short stature in children.
  • Screening for coeliac disease is recommended in children with short stature, particularly those with chronic diarrhoea or anaemia.
  • A gluten-free diet effectively improves growth in affected children.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.1K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
996
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
909